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Abstract: Reproducibility is a hallmark of scientific efforts. Estimates indicate that lack of reproducibility of data 
ranges from 50% to 90% among published research reports. The inability to reproduce major findings of published data 
confounds new discoveries, and importantly, result in wastage of limited resources in the futile effort to build on these 
published reports. This poses a challenge to the research community to change the way we approach reproducibility by 
developing new tools to help progress the reliability of methods and materials we use in our trade. 
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Introduction 
ir Isaac Newton once stated, “If I have seen 
further, it is by standing on the shoulders of 
giants”[1]. He was alluding to the fundamental 
principles underlying the discipline of science — 
which is that we build on previous discoveries. Repli-
cation and corroboration of research findings are a sig-
nificant element to this process. The importance of 
replicating research results cannot be understated — be-
cause the failure to corroborate findings has negative 
consequences on society, sometimes with direct effect 
on human health and welfare. Systematic analyses by 
several independent groups indicate that lack of data 
reproducibility amidst published papers is a bigger 
problem than most scientists may be willing to admit. 
This is a challenge for the research community to col-
lectively respond by developing new processes, stan-
dards, and metrics that are aligned with the way scien-
tists work.  
Real fraudulent intentions in publications are rare, but 
this assertion is one of the first that comes to mind 
when reproducibility problems are presented. The rea-
son for this is largely set in by sensational media 
headlines of scientific misconduct that attract public 
attention. Empirical data from analyses of publications 
since 1992 suggests that real misconduct in scholarly 
works is less than 1% of all publications[2].  
Several teams have attempted systematic investiga-
tions on the lack of reproducibility and reported that a 
large percentage of papers in high impact, peer-rev-
iewed journals cannot be replicated. The lack of re-
producibility was assessed by the inability to replicate 
the major assertion of the publication. Ioannidis et al. 
reported the inability to reproduce 90% of primary 
data from 18 microarray studies[3]; Prinz et al. re-
ported a 65% lack of reproducibility in 67 publica-
tions in oncology, cardiovascular and women’s heal-
th[4]; and Begley and Ellis, found that 89% of oncol-
ogy papers they internally attempted to verify were 
not reproducible in their major claims[5]. The lack of 
reproducibility, at a ballpark frequency of 65% to 89%, 
is much higher than the rate of fraudulent work at 
~1% of publications[2]. These results may indicate that 
there are problems in the way research is corrobora-
ted between research labs, as opposed to outright fraud.  
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Low Reproducibility: Reasons and Impacts 
Here, I primarily focus on non-reproducible work that 
occurs due to routine issues in laboratory processes, 
such as reagent and measurement issues, which might 
address low reproducibility between research groups. 
We researched into the causes of reproducibility by 
interviewing scientists in Switzerland. Researchers 
in biology (n=60, from PhD level students to principal 
scientists), at four institutions (University of Geneva, 
University of Basel, University of Zurich, and École 
Polytechnique Fédérale de Lausanne), were asked 
questions about situations where they were unable to 
reproduce published methods and what might be the 
causes behind this. Of these interviewees, 100% stated 
that they were unable to reproduce published methods 
at one point or another. This survey was not meant 
to be exhaustive, but a starting point to design a study 
for further investigation. We were able to categorize 
their interview responses into the following arguments 
for reasons of low reproducibility of published meth-
ods which I report here as food for thought: 
 Poor quality of reagents, statistical analysis, or 
data measurement methods, 
 Imprecise reporting on the methodological proto-
cols, 
 Inability for direct communication among authors, 
 Complex nature of modern scientific research 
(technically demanding), 
 A lack of accountability for researchers, 
 A publish-or-perish culture in academia that re-
wards quantity over quality of research, 
 Funding bodies and academic journals that value 
“novelty” over replication.  
All of the researchers we surveyed experienced 
frustration in not being to replicate experimental out-
comes. Our survey data exposed that scientists 
would be interested in resources or means to boost the 
reliability of published data. But what is the real im-
pact of this lack of data reproducibility? We lack sys-
tematic data on the economic and societal impact on 
non-reproducible work, because currently these dis-
crepancies are not widely tracked. In comparison, in-
vestigations into papers that were retracted because of 
fraud give a sample accounting of cost and impact of 
non-reproducible work. 
Stern et al. looked into financial costs associated 
with published papers that were retracted between 
1992 and 2012[2]. The team looked for grant numbers 
associated with the publication and traced back the 
amounts of the grant awarded by US funding agencies. 
The total awarded grant was divided by all of the pub-
lications that were associated with the grant number. 
Using a sample set of 43 retracted publications, where 
complete data was available, Stern et al. calculated a 
median financial cost of $239,381 per article (mini-
mum: $7061.95 and maximum: $3,608,713.94)[2]. 
Steen investigated 180 retracted medical papers 
which were primary patient studies conducted be-
tween 2000 and 2010[6]. These papers had been cited 
5000 times. The 180 primary clinical studies and 851 
“secondary” studies (secondary defined as citing the 
original retracted paper), collectively treated 98,501 
patients. Steen also states that “papers retracted for 
fraud (n=70) treated more patients per study (p<0.01) 
than papers retracted for error (n=110)”[6]. Publica-
tions in high impact medical journals are likely to be 
viewed by many clinicians and used to establish 
treatment guideline for patients. For example, a pub-
lished clinical study on hepatocellular carcinoma tre-
atment using chemoembolization and radio frequency 
ablation, was retracted by JAMA in 2009 after a 
post-publication investigation revealed a flaw in the 
experiment design[7]. As not all clinical trial studies 
are published, this estimate of approximately 100,000 
patients being put at risk is conservative because only 
individuals enrolled in published studies were tallied.  
Because non-reproducible elements of publications 
are more numerous than outright fraud, the real cost 
on society is also significant. The obvious negative 
impact is the loss of research time and money inve-
sted by the laboratory attempting to replicate the be-
nchmark data. This effect is compounded globally 
because there is currently no central platform where 
reproducibility of results can be communicated and 
shared. Over time, different labs around the world will 
pick up the same publication and attempt to repeat the 
experiments. The unknown effect of non-reproducible 
data, and perhaps the main indirect cost to society, is 
the hindered rate at which real innovation take place — 
such as the discovery of life-saving treatments for 
diseases. Without the ability to replicate benchmark 
data from publications, novel projects may not even 
get started.  
Federal research funding agencies are paying atten-
tion and are implementing pilot projects to teach better 
methods to design and execute preclinical studies. For 
example, the National Institutes of Health Data Re-
producibility office has developed training modules 
for scientists to improve experimental design[8]. In 
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addition, the recommendations from funding agencies 
and journals are to encourage the use of more appro-
priate statistics, meta-analysis, and transparency with 
regards to publication of methods. However, I believe 
that these efforts do not fully address the data repro-
ducibility issues that are faced by the millions of re-
search scientists around the world. The competitive 
economics of our current science culture favour nov-
elty over reproducibility. This is suggested by the high 
level of retractions that are directly correlated with the 
impact factor of journals[9]. The metrics that measure 
scientific contributions of individuals are skewed to-
ward rewarding “high impact” publications (both with 
grant money and career progression for the investiga-
tors). Journals normally do not publish reproducibility 
reports, and a typical journal contribution has a high 
overhead cost to the authors that limits this reporting. 
Possible Solutions 
I believe that to date, the research community lacks 
practical solutions to help address the roots of the re-
producibility problem adequately. As the Switzerland 
survey of scientists indicated, the lack of transparency 
in research methods is a main hurdle to reproducibility. 
In addition, the variable nature of reagents (e.g., ch-
anging cell lines, impurities in chemical samples) and 
methods to measure and record data, impact the like-
lihood of repeatability. To facilitate an exchange of 
information on these parameters, the research com-
munity needs an independent online platform that al-
lows scientists to publish focused reproducibility reports.  
The “Reproducibility Reporting” platform should 
address many of the shortcomings of current publica-
tion and communication pipelines, while simultane-
ously taking advantage of the digital tools available 
today to enhance engagement and communication 
channels between researchers. For instance, allowing 
rapid publication of focussed reports will decrease the 
time to communicate and broadcast the results from 
reproducibility testing. Although the platform enables 
rapid reporting, the process cannot skimp on assessing 
the quality of the “Reproducibility Report”. Guide-
lines for publishing discrepancy data need to clearly 
articulate the standards for publication, such as mini-
mal statistical testing and carefully evaluating devia-
tions in materials used and methods employed. One 
can imagine that as communities build on the platform, 
discussion parameters will become standardized over 
time to facilitate easier discourse between researchers.   
Sharing the raw data of the reproducibility test will 
also enable insight into the discrepancies. Labs at-
tempting similar methods can examine deviations in 
measurements or in the performance of reagents, such 
as cell lines, more easily. Open Data standards are 
emerging, which are currently used for government 
data, but can be adopted to publish raw science res-
earch data[10]. One advantage of employing Open Data 
standards is that the raw data will have a publication 
record and the original authors are credited for their 
work through citation. An added advantage is that re-
searchers can potentially repurpose the data for a dif-
ferent analysis.   
The current social media platforms, where data re-
producibility is discussed, allow users to anonymously 
post content. This has resulted in posts that attempt to 
discredit publications and hurt the authors’ credibility, 
without fully exploring reasons for the underlying lack 
of data reproducibility. The result is that the scientific 
community turns defensive and discussions of repro-
ducibility problems have a cultural taboo association. 
The ability to facilitate moderated, constructive dia-
logue between peers on the “Reproducibility Reports” 
platform will circumvent the negative aspects of un-
regulated social media platform.  
The straightforward approach to constructive dia-
logue is an empowered and vibrant peer review sys-
tem. The standard journal peer review system uses a 
secret review by 2 to 3 reviewers. However, current 
technology allows crowd-sourcing the review amongst 
expert who may be more versed in that area. Crowd- 
sourcing takes the diversity of opinion of a larger 
number of independent experts who specialize in the 
field and can draw on local knowledge, and aggregates 
this information. Leveraging the wisdom-of-the-crowd 
may enable finding the “diamond in the rough” solu-
tions or identify critical errors in the design of the ex-
periment.  
Anonymity of the reviewer may need to be pre-
served as part of the reviewing process, but because 
all users are validated by the platform, abuse of the 
platform by anonymity is not possible. Exploitation of 
reviewing privileges (such as conflict of interest) 
will be flagged through crowd-sourcing, because in 
small social networks, such as research communities, 
one can more readily identify misuse. To empower 
peer-review, the reviewers’ comments should be visi-
ble to the community. This will increase debate and 
clarification by allowing the community to directly 
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comment on the review itself. But how could one in-
centivize credible and careful peer review by the 
community? I would like to propose an “Open Re-
view” protocol. Scientific peer review of journal arti-
cles in submission is currently a requirement of aca-
demic scholarship. The peer reviewer is not paid, re-
ceives no credit for the review, and remains anony-
mous. Often the peer reviewer may have ideas that can 
advance the investigators’ work. Under “Open Re-
view” guidelines, the peer reviewer is further encour-
aged to improve the work under review bypublishing 
the review as an “opinion” article. By allowing the 
peer review to be published, the reviewer can protect 
their contribution under “creative” license and their 
work can be cited.  
By adhering to “Open Access” guidelines, the global 
research communities can freely engage with the con-
tent created on this platform. Open Access will enable 
a broader reach, in particular, to researchers in devel-
oping countries, which should increase the diversity of 
dialogue on the platform. It is tempting to propose that 
such a platform, which enables faster elucidation of 
what works and what does not work, will enable global 
communities to advance their research programs rapi-
dly. This is because the major output from a reproduci-
bility platform will likely be a “standards database” 
for reagents and measurements that work. 
Conclusion 
It is important to emphasize that the reproducibility 
reports platform is complementary to the current re-
search journals already established. Origination, nov-
elty and innovation of scientific endeavours are still 
the engine that advances society. Communicating the 
reproducible nature of these original articles will stem 
the losses of valuable resources and allow researchers 
to focus on what works. Ideas published in research 
papers influence subsequent research, but vetted re-
producible data will enable more researchers to stand 
on the shoulders of giants.  
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